Last reviewed · How we verify

NCT06770036

Caregiver Implementation Strategies Field Pre-Test

Completed NA Last updated 26 January 2026
What this trial tests

NA trial testing Implementation Resource Package for Caregivers in Attention Deficit Hyperactivity Disorder Symptoms in 20 participants. Completed in 23 January 2026.

Timeline
30 July 2025
Primary endpoint
21 January 2026
23 January 2026

Quick facts

Lead sponsorChildren's Hospital of Philadelphia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment20
Start date30 July 2025
Primary completion21 January 2026
Estimated completion23 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Philadelphia

Who can join

4 and older, any sex, with Attention Deficit Hyperactivity Disorder Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to field pre-test an implementation strategy resource package that aims to support caregivers in using behavioral interventions for children with hyperactive, inattentive, or impulsive behaviors. Enrolled caregivers will be assigned to use the resource package with their children. The research team will collect quantitative and qualitative data regarding acceptability, appropriateness, and feasibility, in preparation for a randomized pilot study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital of Philadelphia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06770036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing